An independent meta-analysis using summary data for clinical response, remission, and discontinuation for any reason from the 6 pivotal phase III randomized clinical trials of duloxetine in major depressive disorder.
Ballesteros
Javier
J
Callado
Luis F
LF
Gutiérrez
Miguel
M
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D017326:Clinical Trials, Phase III as Topic; D003865:Major Depressive Disorder / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D000068736:Duloxetine Hydrochloride; D006801:Humans; D017374:Paroxetine / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012074:Remission Induction; D013876:Thiophenes / Q000627:therapeutic use*; D016896:Treatment Outcome; D028761:Withholding Treatment
D018687:Antidepressive Agents, Second-Generation; D013876:Thiophenes; D017374:Paroxetine; D000068736:Duloxetine Hydrochloride